Pharmaceuticals News

MENLO PARK, Calif. and PARIS, Oct. 06, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, and TychoBio, an AI drug discovery company,...

NeOnc’s (NASDAQ: NTHI) investigational brain-cancer programs, NEO100 and NEO212, have upcoming FDA catalysts

BOCA RATON, FL, Oct. 06, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a late-stage biotechnology company focused on inflammation and immunology, is excited to announce...

Company advances manufacturing scale-up, regulatory testing and preclinical work supporting its planned FDA 510(k) submission in the first quarter of 2027.Multiple scaled-up batches of CXU™ material...

Arcutis’ ZORYVE® (roflumilast) Wins 2026 Marie Claire Beauty Award

60 Degrees plans January 2027 results from its hospitalized babesiosis trial and will seek a pre-sNDA meeting with FDA.

ST. LOUIS, Oct. 06, 2026 (GLOBE NEWSWIRE) -- More than 550 million prescriptions in 2023 were filled for medicines with High or Severe supply-chain fragility, according to new analysis released...

PRINCETON, N.J., Oct. 06, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the...

Telomir secures $5.6 million financing as it advances Telomir-Zn into clinical development under an FDA-cleared IND in TNBC.

CAMBRIDGE, Mass., Oct. 06, 2026 (GLOBE NEWSWIRE) -- OHB Pediatrics Ltd d/b/a Oak Hill Bio, a clinical-stage rare disease therapeutics company, today announced the appointment of Joerg Hipp, PhD as...